Zhejiang Shengda Bio-Pharm Co (SHSE:603079) Moat Score: 0/10 (As of Jul. 26, 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

SHSE:603079 Zhejiang Shengda Bio-Pharm Co Ltd SHSE:603079
61 GF Score
Price ¥10.04
GF Value ¥14.40
Valuation Significantly Undervalued
! 5 Warning Signs
View Full Analysis

What is Zhejiang Shengda Bio-Pharm Co Moat Score?

Zhejiang Shengda Bio-Pharm Co has the Moat Score of 0, which implies that the company might have No Moat - No discernible moat.

Zhejiang Shengda Bio-Pharm Co has

Moat Score is a ranking system developed by GuruFocus to assess a company's ability to sustain a competitive advantage, rated on a scale from 0 to 10. It takes into account key factors such as market leadership, cost advantages, network effects, customer switching costs, and more.

The company's Moat Score is based on these criteria:

1. Market leadership and sustainable market share
2. Network effects and significant customer switching costs
3. Valuable intellectual property and patents
4. Strong brand strength and deep customer loyalty
5. Durable cost advantages (e.g., economies of scale, proprietary technology)
6. Significant regulatory barriers and exclusive licenses
7. Superior distribution network
8. Strong and sustainable pricing power
9. Consistent and impactful innovation and R&D capabilities

Based on the research, GuruFocus believes Zhejiang Shengda Bio-Pharm Co might have No Moat - No discernible moat.

Zhejiang Shengda Bio-Pharm Co  (SHSE:603079) Moat Score Explanation

The Moat Score ranges from 0 to 10, with 10 as the highest. GuruFocus divided Moat Score into following 8 categories:

Moat Score Moat Level
10Wide Moat - Exceptionally dominant and durable wide moat
8 - 9Wide Moat - Clear and robust wide moat
7Wide Moat - Entry-level wide moat, clearly possessing durable advantages
6Narrow Moat - Strong narrow moat, clearly distinguishable but not wide
5Narrow Moat - Solid narrow moat
4Narrow Moat - Discernible but modest moat
1 - 3No Moat - Very weak/transient advantages
0No Moat - No discernible moat

Zhejiang Shengda Bio-Pharm Co Moat Score Related Terms

SHSE:603079
61GF Score
Zhejiang Shengda Bio-Pharm Co Ltd SHSE:603079
Moat Score is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Is Zhejiang Shengda Bio-Pharm Co (SHSE:603079) Overvalued in 2026?

Based on GuruFocus' analysis, Zhejiang Shengda Bio-Pharm Co stock appears to be undervalued. The current stock price of ¥10.04 is trading 30.3% below its estimated GF Value™ of ¥14.40. GuruFocus considers Zhejiang Shengda Bio-Pharm Co to be Significantly Undervalued.

Key valuation signals for SHSE:603079:

  • Moat Score: 0
  • GF Value™: ¥14.40 vs. price of ¥10.04 (30.3% below fair value)
  • GF Score™: 61/100 with 5 warning signs

No single metric tells the full story. See the SHSE:603079 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Zhejiang Shengda Bio-Pharm Co Business Description

Address No.789, Renmin East Road, Chicheng Street, Tiantai County, Zhejiang Province, Hangzhou, CHN, 317200
Zhejiang Shengda Bio-Pharm Co Ltd is a pharmaceutical company. It is mainly engaged in the research and development, and production of biotin and biological preservatives. Its product portfolio includes biotin, folic acid, and other vitamin products, nisin, natamycin, and sucrose fermentation products.
61GF Score

Get the complete analysis for SHSE:603079

Moat Score is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

¥10.04
Price
¥14.40
GF Value